GT Biopharma Raises $7.45 Million in Series M Preferred Offering With Warrants, Adds Greenshoe
GT Biopharma announced a private placement of Series M 10% Convertible Preferred Stock and warrants for $7.45 million in gross proceeds ($8.28 million stated value), featuring conversion at $6.10 and full ratchet protections. Purchasers received five-year warrants equal to 100% of the conversion sh…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.